Cargando…
Short-chain fatty acids–microbiota crosstalk in the coronavirus disease (COVID-19)
The novel coronavirus disease (COVID-19) still remains a major challenge to the health-care systems worldwide, inciting ongoing search for pharmaceutical and non-pharmaceutical interventions which could benefit patients already infected with SARS-CoV-2 or at increased risk thereof. Although SARS-CoV...
Autores principales: | Włodarczyk, Jakub, Czerwiński, Bartłomiej, Fichna, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513287/ https://www.ncbi.nlm.nih.gov/pubmed/36166147 http://dx.doi.org/10.1007/s43440-022-00415-7 |
Ejemplares similares
-
Oxygen Binding by Co(II) Complexes with Oxime-Containing Schiff Bases in Solution
por: Pająk, Marek, et al.
Publicado: (2022) -
Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers
por: Son, Mi-Young, et al.
Publicado: (2023) -
Management of Pelvic Pain in Patients with Crohn’s Disease—Current Overview
por: Włodarczyk, Jakub, et al.
Publicado: (2023) -
The Urinary Microbiome; Axis Crosstalk and Short-Chain Fatty Acid
por: Yang, Hee Jo, et al.
Publicado: (2022) -
Critical interactions between opioid and cannabinoid receptors during tolerance and physical dependence development to opioids in the murine gastrointestinal tract: proof of concept
por: Szymaszkiewicz, Agata, et al.
Publicado: (2021)